Additionally, SMG’s newly-formed diagnostic & aesthetics segment – which was established following the 2016 acquisition of two of the group’s subsidiaries, Novena Radiology (NRPL) and Lifescan Imaging (LSI) – saw a 31.9% revenue increase to $11.2 million.
SINGAPORE (Feb 27): Singapore Medical Group (SMG), the healthcare services provider, has swung back into profitability for FY16 with record earnings of $2.4 million on higher revenue.
Group revenue for the full year ended Dec 31 surged 34.3% on-year to $41.6 million, mainly driven by contributions from the healthcare segment, which grew 35% to $29.9 million.
